A new volume in the
Surgical Pathology: Case-Based Approach to Diagnosis series,
Dermatopathology offers a practical, real-world approach to this complex area of surgical pathology.
Actual cases, highlighted by hundreds of high-quality clinical and histologic photographs, help you learn and retain key information, including which pathologic findings are clinically significant and which are not. Useful as
both an everyday bench-side reference and as an
authoritative review for certification and recertification exams, this resource uses diagnostically relevant cases to teach how to evaluate and interpret even the most challenging lesions.
- Discusses advances in molecular diagnostic testing, its capabilities and its limitations, including targeted and personalized medicine
- Incorporates the latest TNM staging and WHO classification systems, as well as new diagnostic biomarkers and their utility in differential diagnosis, newly described variants, and new histologic entities
- Integrates dermatopathology, clinical correlations, and clinical photographs throughout
- Features up-to-date information on biologics, drug eruptions, and other developments in therapeutics
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
Dr. Tim McCalmont has spent his entire career in the academic practice of dermatopathology and has served as a tertiary dermatopathology consultant at the UCSF Dermatopathology Service for over 2 decades. Dr. McCalmont has a keen interest in all aspects of cutaneous pathology but is particularly intrigued by adnexal tumors, melanocytic tumors, and advanced diagnostic techniques, including both sophisticated immunohistochemistry and molecular methods. He is the editor-in-chief of the Journal of Cutaneous Pathology.
Dr Michael Tetzlaff recently moved to UCSF from the Department of Pathology and Translational and Molecular Pathology at the MD Anderson Cancer Centre at The University of Texas. Prof Tetzlaff’ s main area of expertise is in primary mucosal melanoma and merkel cell carcinoma, and assisting in the assessment of pathological samples from patients undergoing neoadjuvant, targeted therapy. He is the author of over 100 peer-reviewed journal articles
Erik A. Williams works in the Department of Pathology, University of California San Francisco.
